Master’s student in biology at Uppsala university, and organiser for a local EA group (EA Uppsala).
I was also thinking of the high production costs as a potential area of intervention. A few minutes of browsing turned up some potential advancements in production methods of antivenom, e.g. using synthetic biology, and I would be interested in learning about the potential cost-effectiveness of implementing or scaling up such alternative production methods. It seems like many of them are still in the R&D-stage though, but this could be an area to keep a close eye on.
A recent article on the topic:
https://www.drugdiscoverynews.com/snakebite-antivenoms-step-into-the-future-15378
Hello! I'm Jesper, I'm in a master's program in biology at Uppsala University. I'm trying to test my fit for biosecurity and figuring out my career plan. I think biological questions will grow in importance in the future as biotech capabilities improve, and so bioethics will similarly be of increasing value.